Luciana Vieira
Luciana Vieira has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Joanne L. Stone
Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, USA
2 shared publicationsAlan B. Copperman
Sema4, Stamford, USA
1 shared publicationAmanda B. Zheutlin
Sema4, Stamford, USA
1 shared publication- Andrei Rebarber
Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York
1 shared publication Bahman Tabaei
Department of Health & Mental Hygiene, Bureau of Vital Statistics, New York City
1 shared publicationBoshu Ru
Sema4, Stamford, USA
1 shared publication
Latest Publications
- 21 August 2023
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 41 (S 01) , e2752-e2758
Predictors and Trends in First-Trimester Hemoglobin A1c Screening in New York City, 2009 to 2017
Glycated hemoglobin is an adjunct tool in early pregnancy to assess glycemic control. We examined trends and maternal predictors for those who had A1c screening in early pregnancy using hospital discharge and vital registry data between 2009 and 2017 linked with the New York City A1C Registry (N = 798,312). First-trimester A1c screening increased from 2.3% in 2009 to 7.7% in 2017. The likelihood of screening became less targeted to high-risk patients over time, with a decrease in mean A1c values from 5.8% (95% confidence interval [CI]: 5.8, 5.9) to 5.3 (95% CI: 5.3, 5.4). The prevalence of gestational diabetes mellitus increased while testing became less discriminate for those with high-risk factors, including pregestational type 2 diabetes, chronic hypertension, obesity, age over 40 years, as well as Asian or Black non-Hispanic race/ethnicity. Key Points
- 21 August 2023
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 41 (S 01) , e2752-e2758
Predictors and Trends in First-Trimester Hemoglobin A1c Screening in New York City, 2009 to 2017
Glycated hemoglobin is an adjunct tool in early pregnancy to assess glycemic control. We examined trends and maternal predictors for those who had A1c screening in early pregnancy using hospital discharge and vital registry data between 2009 and 2017 linked with the New York City A1C Registry (N = 798,312). First-trimester A1c screening increased from 2.3% in 2009 to 7.7% in 2017. The likelihood of screening became less targeted to high-risk patients over time, with a decrease in mean A1c values from 5.8% (95% confidence interval [CI]: 5.8, 5.9) to 5.3 (95% CI: 5.3, 5.4). The prevalence of gestational diabetes mellitus increased while testing became less discriminate for those with high-risk factors, including pregestational type 2 diabetes, chronic hypertension, obesity, age over 40 years, as well as Asian or Black non-Hispanic race/ethnicity. Key Points
- Open Access
- 6 June 2022
- Published by Springer Nature in npj Digital Medicine
- Vol. 5 (1) , 1-16
Improving preeclampsia risk prediction by modeling pregnancy trajectories from routinely collected electronic medical record data
Preeclampsia is a heterogeneous and complex disease associated with rising morbidity and mortality in pregnant women and newborns in the US. Early recognition of patients at risk is a pressing clinical need to reduce the risk of adverse outcomes. We assessed whether information routinely collected in electronic medical records (EMR) could enhance the prediction of preeclampsia risk beyond what is achieved in standard of care assessments. We developed a digital phenotyping algorithm to curate 108,557 pregnancies from EMRs across the Mount Sinai Health System, accurately reconstructing pregnancy journeys and normalizing these journeys across different hospital EMR systems. We then applied machine learning approaches to a training dataset (N = 60,879) to construct predictive models of preeclampsia across three major pregnancy time periods (ante-, intra-, and postpartum). The resulting models predicted preeclampsia with high accuracy across the different pregnancy periods, with areas under the receiver operating characteristic curves (AUC) of 0.92, 0.82, and 0.89 at 37 gestational weeks, intrapartum and postpartum, respectively. We observed comparable performance in two independent patient cohorts. While our machine learning approach identified known risk factors of preeclampsia (such as blood pressure, weight, and maternal age), it also identified other potential risk factors, such as complete blood count related characteristics for the antepartum period. Our model not only has utility for earlier identification of patients at risk for preeclampsia, but given the prediction accuracy exceeds what is currently achieved in clinical practice, our model provides a path for promoting personalized precision therapeutic strategies for patients at risk.
- 6 June 2022
- Published by Springer Nature in npj Digital Medicine
- Vol. 5 (1) , 1-16
Open AccessImproving preeclampsia risk prediction by modeling pregnancy trajectories from routinely collected electronic medical record data
Preeclampsia is a heterogeneous and complex disease associated with rising morbidity and mortality in pregnant women and newborns in the US. Early recognition of patients at risk is a pressing clinical need to reduce the risk of adverse outcomes. We assessed whether information routinely collected in electronic medical records (EMR) could enhance the prediction of preeclampsia risk beyond what is achieved in standard of care assessments. We developed a digital phenotyping algorithm to curate 108,557 pregnancies from EMRs across the Mount Sinai Health System, accurately reconstructing pregnancy journeys and normalizing these journeys across different hospital EMR systems. We then applied machine learning approaches to a training dataset (N = 60,879) to construct predictive models of preeclampsia across three major pregnancy time periods (ante-, intra-, and postpartum). The resulting models predicted preeclampsia with high accuracy across the different pregnancy periods, with areas under the receiver operating characteristic curves (AUC) of 0.92, 0.82, and 0.89 at 37 gestational weeks, intrapartum and postpartum, respectively. We observed comparable performance in two independent patient cohorts. While our machine learning approach identified known risk factors of preeclampsia (such as blood pressure, weight, and maternal age), it also identified other potential risk factors, such as complete blood count related characteristics for the antepartum period. Our model not only has utility for earlier identification of patients at risk for preeclampsia, but given the prediction accuracy exceeds what is currently achieved in clinical practice, our model provides a path for promoting personalized precision therapeutic strategies for patients at risk.
- Open Access
- 29 April 2021
- Published by Levy Library Press in ISMMS Journal of Science and Medicine
- Vol. 1 (2)
Assessing the Impact of the COVID-19 Pandemic on Postpartum Contraception Uptake
- 29 April 2021
- Published by Levy Library Press in ISMMS Journal of Science and Medicine
- Vol. 1 (2)
Open AccessAssessing the Impact of the COVID-19 Pandemic on Postpartum Contraception Uptake
- 1 September 2019
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 221 (3) , 253.e1-253.e8
Comparing pregnancy outcomes and loss rates in elective twin pregnancy reduction with ongoing twin gestations in a large contemporary cohort
- 1 September 2019
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 221 (3) , 253.e1-253.e8
Comparing pregnancy outcomes and loss rates in elective twin pregnancy reduction with ongoing twin gestations in a large contemporary cohort